Biomarkers and Disease Activity in Patients Treated With Teriflunomide (Aubagio)

Clinical trial NCT03561402 · COMPLETED

Trial details

NCT number: NCT03561402
Sponsor: McGill University
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2016-12-01
Primary completion: 2020-12-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.